Elodie Péraudeau

592 total citations
16 papers, 484 citations indexed

About

Elodie Péraudeau is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Elodie Péraudeau has authored 16 papers receiving a total of 484 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Organic Chemistry and 5 papers in Oncology. Recurrent topics in Elodie Péraudeau's work include Glycosylation and Glycoproteins Research (6 papers), Cancer Treatment and Pharmacology (4 papers) and Click Chemistry and Applications (3 papers). Elodie Péraudeau is often cited by papers focused on Glycosylation and Glycoproteins Research (6 papers), Cancer Treatment and Pharmacology (4 papers) and Click Chemistry and Applications (3 papers). Elodie Péraudeau collaborates with scholars based in France, Canada and Ukraine. Elodie Péraudeau's co-authors include Jonathan Clarhaut, Sébastien Papot, Brigitte Renoux, Pauline Poinot, Isabelle Tranoy‐Opalinski, Thibaut Legigan, David A. Leigh, Antony E. Fernandes, Vincent Aucagne and Stéphanie Lerondel and has published in prestigious journals such as Angewandte Chemie International Edition, Chemical Communications and Journal of Controlled Release.

In The Last Decade

Elodie Péraudeau

16 papers receiving 484 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elodie Péraudeau France 12 252 229 122 108 94 16 484
Thibaut Legigan France 15 407 1.6× 370 1.6× 133 1.1× 112 1.0× 121 1.3× 26 748
Ahmed Alouane France 7 249 1.0× 224 1.0× 83 0.7× 97 0.9× 129 1.4× 8 479
Kazuhito Tanabe Japan 17 380 1.5× 234 1.0× 70 0.6× 170 1.6× 181 1.9× 52 749
George R. Negrete United States 13 268 1.1× 251 1.1× 176 1.4× 139 1.3× 58 0.6× 32 652
Lan Yao United States 12 342 1.4× 154 0.7× 150 1.2× 161 1.5× 53 0.6× 23 611
Geoffray Leriche United States 13 392 1.6× 239 1.0× 90 0.7× 106 1.0× 97 1.0× 28 612
John McEwan Australia 8 213 0.8× 151 0.7× 103 0.8× 123 1.1× 70 0.7× 10 479
Cynthia L. Schreiber United States 15 240 1.0× 203 0.9× 90 0.7× 245 2.3× 204 2.2× 20 631
Eline Bartolami France 14 626 2.5× 366 1.6× 131 1.1× 67 0.6× 96 1.0× 18 822
Diana Groza Austria 11 250 1.0× 167 0.7× 93 0.8× 92 0.9× 74 0.8× 15 585

Countries citing papers authored by Elodie Péraudeau

Since Specialization
Citations

This map shows the geographic impact of Elodie Péraudeau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elodie Péraudeau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elodie Péraudeau more than expected).

Fields of papers citing papers by Elodie Péraudeau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elodie Péraudeau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elodie Péraudeau. The network helps show where Elodie Péraudeau may publish in the future.

Co-authorship network of co-authors of Elodie Péraudeau

This figure shows the co-authorship network connecting the top 25 collaborators of Elodie Péraudeau. A scholar is included among the top collaborators of Elodie Péraudeau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elodie Péraudeau. Elodie Péraudeau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Péraudeau, Elodie, Brigitte Renoux, Sheik Emambux, et al.. (2023). Combination of Targeted Therapies for Colorectal Cancer Treatment. Molecular Pharmaceutics. 20(9). 4537–4545. 6 indexed citations
2.
Péraudeau, Elodie, Jonathan Clarhaut, Claude Geffroy, et al.. (2022). A β-Cyclodextrin-Albumin Conjugate for Enhancing Therapeutic Efficacy of Cytotoxic Drugs. Bioconjugate Chemistry. 33(6). 1138–1144. 2 indexed citations
3.
Péraudeau, Elodie, Pauline Poinot, Stéphanie Lerondel, et al.. (2020). In vivo synthesis of triple-loaded albumin conjugate for efficient targeted cancer chemotherapy. Journal of Controlled Release. 327. 19–25. 22 indexed citations
4.
Boucher, Jonathan, Marjolaine Debant, Thomas Harnois, et al.. (2020). Cx43 Present at the Leading Edge Membrane Governs Promigratory Effects of Osteoblast-Conditioned Medium on Human Prostate Cancer Cells in the Context of Bone Metastasis. Cancers. 12(10). 3013–3013. 7 indexed citations
5.
Porte, Karine, Brigitte Renoux, Elodie Péraudeau, et al.. (2019). Controlled Release of a Micelle Payload via Sequential Enzymatic and Bioorthogonal Reactions in Living Systems. Angewandte Chemie International Edition. 58(19). 6366–6370. 56 indexed citations
6.
Porte, Karine, Brigitte Renoux, Elodie Péraudeau, et al.. (2019). Controlled Release of a Micelle Payload via Sequential Enzymatic and Bioorthogonal Reactions in Living Systems. Angewandte Chemie. 131(19). 6432–6436. 11 indexed citations
7.
Péraudeau, Elodie, et al.. (2019). Volatile Organic Compound Based Probe for Induced Volatolomics of Cancers. Angewandte Chemie International Edition. 58(49). 17563–17566. 36 indexed citations
8.
Péraudeau, Elodie, et al.. (2019). Volatile Organic Compound Based Probe for Induced Volatolomics of Cancers. Angewandte Chemie. 131(49). 17727–17730. 3 indexed citations
9.
Compain, Guillaume, Nassima Oumata, Jonathan Clarhaut, et al.. (2018). A β-glucuronidase-responsive albumin-binding prodrug for potential selective kinase inhibitor-based cancer chemotherapy. European Journal of Medicinal Chemistry. 158. 1–6. 23 indexed citations
10.
Renoux, Brigitte, et al.. (2018). A β-glucuronidase-responsive albumin-binding prodrug programmed for the double release of monomethyl auristatin E. MedChemComm. 9(12). 2068–2071. 18 indexed citations
11.
Péraudeau, Elodie, Laurent Cronier, Arnaud Monvoisin, et al.. (2017). Enhancing tumor response to targeted chemotherapy through up-regulation of folate receptor α expression induced by dexamethasone and valproic acid. Journal of Controlled Release. 269. 36–44. 16 indexed citations
12.
Renoux, Brigitte, Thibaut Legigan, Elodie Péraudeau, et al.. (2017). Targeting the tumour microenvironment with an enzyme-responsive drug delivery system for the efficient therapy of breast and pancreatic cancers. Chemical Science. 8(5). 3427–3433. 101 indexed citations
13.
Legigan, Thibaut, Isabelle Tranoy‐Opalinski, Brigitte Renoux, et al.. (2015). A mechanically interlocked molecular system programmed for the delivery of an anticancer drug. Chemical Science. 6(4). 2608–2613. 130 indexed citations
14.
Alsarraf, Jérôme, Elodie Péraudeau, Pauline Poinot, et al.. (2015). A dendritic β-galactosidase-responsive folate–monomethylauristatin E conjugate. Chemical Communications. 51(87). 15792–15795. 17 indexed citations
15.
Legigan, Thibaut, Jonathan Clarhaut, Elodie Péraudeau, et al.. (2013). An enzyme-responsive system programmed for the double release of bioactive molecules through an intracellular chemical amplification process. Organic & Biomolecular Chemistry. 11(41). 7129–7129. 21 indexed citations
16.
Clarhaut, Jonathan, Sylvain Fraineau, Joëlle Guilhot, et al.. (2013). A galactosidase-responsive doxorubicin-folate conjugate for selective targeting of acute myelogenous leukemia blasts. Leukemia Research. 37(8). 948–955. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026